EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analyses

Yu-Wei Lin, Anna Largajolli, A Yin Edwards, S Y Amy Cheung, Kashyap Patel, Stefanie Hennig

Frontiers in Pharmacology · 16.01.2025 · 15

DOI: 10.3389/fphar.2024.1487062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 16.01.2025. Verfasst von Yu-Wei Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Certara Inc., Melbourne, VIC, Australia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exposure-response (ER) analyses are routinely performed as part of model-informed drug development to evaluate the risk-to-benefit ratio for dose selection, justification, and confirmation. For logistic regression analyses with binary endpoints, several exposure metrics are investigated, based on pharmacological plausibility, including time-averaged concentration to event (C avTE ). C avTE is informative because it accounts for dose interruptions, modifications, and reductions and is therefore often compared against ER relationships identified using steady-state exposures. However, its derivation requires consideration in a logistic regression framework for time-invariant ER analysis because it has the potential to introduce bias. This study evaluated different approaches to derive C avTE for subjects whom did not have an event by the end of treatment (EoT) and assessed their impact on the ER relationship. Here we used a modified model based on a real data example for simulating exposures and events (safety) in different virtual population sizes (n = 50, 100, or 200) and drug effect magnitudes (0.5, 0.75, or 1). Events were generated using a proportional odds model with Markov components. For subjects whom did not experience an event, C avTE was derived at EoT, EoT+7 days, +14 days, +21 days, +28 days. The derivation of C avTE at different time points demonstrated significant impact on trends detected in logistic ER relationships that could bias subsequent event projection, dose selection and Go/No-Go decisions. C avTE in censored subjects must therefore be carefully derived to avoid potentially making false positive or negative conclusions. Overall, C avTE can be a useful exposure metrics in an ER analysis, when considered along with physiological or biological plausibility, the drug’s pharmacokinetic, and mechanism of action. Biological plausibility and different analysis factors (e.g., the time of the events with respect to observational period, the level of dose reduction/interruption) should be considered in the choice of the exposure metric. It is recognized that although time-invariant logistic regression is relatively fast and efficient, it overlooks recurring events and does not take into account the exposure and response time course with the potential drawback of ignoring important elements of the analysis like onset or duration of the effect. Care should be taken when ER relationships with other exposure metrics do not identify any statistically significant trends.

Schlagwörter

Stichwörter der Autor:innen

drug developmentexposure metricsexposure-response analysislogistic regressionpharmacometrics

Autor:innen und Institutionen

  • Certara Inc., Melbourne, VIC, Australia.
  • Monash Biomedicine Discovery Institute, Infection Program and Department of Microbiology, Monash University, Clayton, VIC, Australia.
  • Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
  • Malaya Translational and Clinical Pharmacometrics Group, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia.
  • Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia.
  • Certara Inc., Princeton, NJ, United States.

Zitieren

APA

Lin, Y. W., Largajolli, A., Edwards, A. Y., Cheung, S. Y. A., Patel, K., & Hennig, S. (2025). Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analyses. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1487062

Vancouver

Lin YW, Largajolli A, Edwards AY, Cheung SYA, Patel K, Hennig S. Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analyses. Frontiers in Pharmacology. 2025;15. doi:10.3389/fphar.2024.1487062

BibTeX
@article{Lin2025,
  author = {Lin, Yu-Wei and Largajolli, Anna and Edwards, A Yin and Cheung, S Y Amy and Patel, Kashyap and Hennig, Stefanie},
  title = {Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analyses},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fphar.2024.1487062}
}
Kostenlos starten →